|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2011-2-4
|
|
pubmed:abstractText |
There is an ongoing discussion as to whether monitoring of cyclosporine (CsA)-based immunosuppression with plasma levels two hours after medication intake (C2) offers clinical benefit over the measurement of CsA trough levels (C0) in patients after heart transplantation (HTx). In particular, data from long-term maintenance patients are not available.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1424-3997
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
141
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
w13149
|
|
pubmed:meshHeading |
pubmed-meshheading:21293979-Aged,
pubmed-meshheading:21293979-Biopsy,
pubmed-meshheading:21293979-Continuity of Patient Care,
pubmed-meshheading:21293979-Cyclosporine,
pubmed-meshheading:21293979-Dose-Response Relationship, Drug,
pubmed-meshheading:21293979-Graft Rejection,
pubmed-meshheading:21293979-Heart Transplantation,
pubmed-meshheading:21293979-Humans,
pubmed-meshheading:21293979-Immunosuppressive Agents,
pubmed-meshheading:21293979-Middle Aged,
pubmed-meshheading:21293979-Switzerland
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Cyclosporine C0- versus C2-monitoring over three years in maintenance heart transplantation.
|
|
pubmed:affiliation |
Cardiovascular Center Cardiology, University Hospital Zürich, Rämistrasse 100, 8091 Zürich, Switzerland. mhermann@gmx.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
